Orion Corp
KRX:271560

Watchlist Manager
Orion Corp Logo
Orion Corp
KRX:271560
Watchlist
Price: 104 800 KRW -0.47% Market Closed
Market Cap: 4.1T KRW
Have any thoughts about
Orion Corp?
Write Note

Orion Corp
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Orion Corp
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Orion Corp
KRX:271560
Short-Term Investments
â‚©725.5B
CAGR 3-Years
90%
CAGR 5-Years
57%
CAGR 10-Years
N/A
CJ CheilJedang Corp
KRX:097950
Short-Term Investments
â‚©601B
CAGR 3-Years
-3%
CAGR 5-Years
14%
CAGR 10-Years
1%
Ottogi Corp
KRX:007310
Short-Term Investments
â‚©328.8B
CAGR 3-Years
-5%
CAGR 5-Years
8%
CAGR 10-Years
4%
S
Samyang Foods Co Ltd
KRX:003230
Short-Term Investments
â‚©22.3B
CAGR 3-Years
-10%
CAGR 5-Years
10%
CAGR 10-Years
10%
Dongwon Industries Co Ltd
KRX:006040
Short-Term Investments
â‚©535.9B
CAGR 3-Years
27%
CAGR 5-Years
21%
CAGR 10-Years
22%
Nongshim Co Ltd
KRX:004370
Short-Term Investments
â‚©617.4B
CAGR 3-Years
28%
CAGR 5-Years
9%
CAGR 10-Years
6%
No Stocks Found

Orion Corp
Glance View

Market Cap
4.1T KRW
Industry
Food Products

Perched within the competitive landscape of pharmaceuticals, Orion Corporation has steadily carved its niche since its inception in Finland in 1917. Starting as a small-scale factory operation, Orion has evolved into a pivotal player in the healthcare sector, blending traditional expertise with cutting-edge innovations. The company's core operations pivot around the development, manufacturing, and marketing of human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). This dual focus allows Orion not only to reach a diverse market but also ensures a consistent revenue stream, supplemented by its strategic interest in self-care products. The company thrives on its robust research and development arm, constantly seeking innovations in therapeutic areas like central nervous system disorders, oncology, and respiratory diseases. Orion's financial engine hums efficiently through its vertically integrated business model. By managing most of the value chain internally—from drug discovery to production and distribution—Orion secures cost advantages and quality control, translating into a competitive edge in global markets. While Europe remains Orion's stronghold, it strategically seeks growth in regional markets, leveraging partnerships and alliances with international pharmaceutical giants to expand its footprint. This strategy not only augments its own pipeline with licensed products but also fortifies its market position, making it a sustainable player in an industry driven by constant change and regulated rigorously. The corporation's revenue streams thus embody a careful balance of organic product development and strategic collaborations, evidencing a business acumen grounded in long-term vision.

Intrinsic Value
153 695.88 KRW
Undervaluation 32%
Intrinsic Value
Price

See Also

What is Orion Corp's Short-Term Investments?
Short-Term Investments
725.5B KRW

Based on the financial report for Sep 30, 2024, Orion Corp's Short-Term Investments amounts to 725.5B KRW.

What is Orion Corp's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
57%

Over the last year, the Short-Term Investments growth was 0%. The average annual Short-Term Investments growth rates for Orion Corp have been 90% over the past three years , 57% over the past five years .

Back to Top